Cargando…

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy

PURPOSE: To determine whether the presence of vitreomacular interface abnormalities (VMIA) in patients with diabetic macular oedema (DMO) modifies the response to ranibizumab. METHODS: Medical records and spectral-domain optical coherence tomography (SD-OCT) scans of consecutive patients with centre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikhail, Michael, Stewart, Stephen, Seow, Felicia, Hogg, Ruth, Lois, Noemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060772/ https://www.ncbi.nlm.nih.gov/pubmed/29779188 http://dx.doi.org/10.1007/s00417-018-4009-6

Ejemplares similares

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
por: Wong, Yun, et al.
Publicado: (2016)

Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes
por: Baumann, Carmen, et al.
Publicado: (2022)

A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit)
por: Stalmans, Peter
Publicado: (2016)

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2021)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration
por: Quist, S. W., et al.
Publicado: (2021)

Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021)

Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment
por: Zola, Marta, et al.
Publicado: (2020)

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021)

See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment
por: Enders, Christian, et al.
Publicado: (2022)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19
por: Stone, Lydia G., et al.
Publicado: (2020)

Choroidal thickness in lamellar macular holes
por: Kal, Magdalena, et al.
Publicado: (2020)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022)

Fixation behavior in macular dystrophy assessed by microperimetry
por: Chiang, Wei-Yu, et al.
Publicado: (2018)

Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography
por: Guemes-Villahoz, Noemi, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

A retrospective, multicenter study on the management of macular holes without residual internal limiting membrane: the refractory macular hole (ReMaHo) study
por: Lorenzi, Umberto, et al.
Publicado: (2022)

Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
por: Matsubara, Hisashi, et al.
Publicado: (2022)

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
por: Granstam, Elisabet, et al.
Publicado: (2021)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration
por: Nishiguchi, Fumi, et al.
Publicado: (2020)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment
por: Ando, Yoshimasa, et al.
Publicado: (2016)

Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration
por: Cozzi, Mariano, et al.
Publicado: (2021)

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
por: Marquis, Liza-Marie, et al.
Publicado: (2020)

Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy
por: Schworm, Benedikt, et al.
Publicado: (2021)

The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
por: Parvin, Parmis, et al.
Publicado: (2017)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
por: Pellegrini, Marco, et al.
Publicado: (2020)

Comparison of swept-source versus spectral-domain optical coherence tomography angiography for detection of macular neovascularization
por: Lentzsch, Anna, et al.
Publicado: (2021)

Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation
por: Nakai, Mitsuko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gl65o8kimhucavoqnk6b3fb7lc